Sugi Predict

Sugi Predict / Compounds / SCHEMBL24253606

SCHEMBL24253606

SCHEMBL24253606

O=C1CCCC2(CCN(c3cc(Cl)nn(Cc4ccccc4)c3=O)CC2)N1c1ccc(F)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.38
▸ HCRTR2 O43614 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ LTC4S Q16873 1/20 0.38
▸ MAPT P10636 6/20 0.37
▸ TP53 P04637 5/20 0.37
▸ NPSR1 Q6W5P4 5/20 0.35
▸ MEN1 O00255 5/20 0.35
▸ KMT2A Q03164 5/20 0.35
▸ LMNA P02545 4/20 0.35
▸ HTT P42858 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ HTR1A P08908 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ RIPK1 Q13546 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30494667 0.98 HCRTR1 (0.37) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL26307796 0.88 HCRTR1 (0.38) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL24253519 0.83 HCRTR1 (0.33) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL24253607 0.77 HTR1A (0.35) MAPTTP53HTR1ADRD2ADRA1D
SCHEMBL24253924 0.77 NPSR1 (0.36) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL30423985 0.73 HCRTR1 (0.35) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL24253866 0.73 HCRTR1 (0.35) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL24253605 0.72 NPSR1 (0.43) MAPTNPSR1MEN1KMT2ALMNA
SCHEMBL24253552 0.72 MAPT (0.40) HCRTR1HCRTR2KCNH2LTC4SMAPT
SCHEMBL30423245 0.72 MAPT (0.40) HCRTR1HCRTR2KCNH2LTC4SMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof NOVARTIS AG (CH) 2023-07-25 — — US disclosed
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof NOVARTIS AG (CH) 2023-07-25 — — US disclosed
EP-4196478-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF Novartis AG (CH) 2023-06-21 — — EP disclosed
CN-116157404-A Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof 诺华股份有限公司 2023-05-23 — — CN disclosed
US-20220048909-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708366-B2 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof REN, NR3C2, PKD1 HCRTR1 2245/4885HCRTR2 3027/4885KCNH2 282/4885
US-20220048909-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF REN, NR3C2, PKD1 HCRTR1 2245/4885HCRTR2 3027/4885KCNH2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.